ASCO Publicity

Not sure how many get news feeds, but the coverage of SRX and ASCO presentation as been very wide spread. From TV, to national and local papers, in Aus, US , UK and others. I'd expect many of the oncology journals to print details over the coming weeks. I must have had over 30 alerts today.

This expansion of public awareness should, I hope, drive the most unfortunate souls who are diagnosed with this affliction, to at least ask their oncologist about the possibility of SIRT treatment.

Not a benefit for all mCRC suffers, but for a good % it would probably be a beneficial process.

There can't be that big of a % of oncologists that have not read the data by now.

Dose sales over the coming 6 months will be key for expanding sales into the mCRC market. Along with expansion into other countries, one could assume. We will see next Feb.